What's happened
Documentary on Theranos founder Elizabeth Holmes has sparked varied reactions in tech circles as audiences, investors and insiders react to the film and its portrayal of Holmes’ rise and fall, with new details about Evans and Theranos 2.0 coming to light.
What's behind the headline?
Analysis
- The film’s reception is split: some see it as a critical mirror on tech hucksterism, others argue it sensationalizes individuals involved. This reflects broader tensions about accountability in tech entrepreneurship.
- The narrative arc ties Holmes’ Theranos saga to a potential revival by Evans, raising questions about whether Silicon Valley forgiveness is possible or if the industry’s booster culture remains intact.
- Readers should watch for how the documentary shapes public perception of Holmes and whether it influences investors’ caution in healthcare tech ventures.
How we got here
Theranos once reached a multi‑billion dollar valuation before collapsing amid fraud convictions. The film follows Holmes and her partner Billy Evans as their personal and professional lives intersect with a new startup push, set against ongoing scrutiny of Silicon Valley culture.
Our analysis
Business Insider UK has run multiple pieces, including reactions from tech figures and summaries of scenes. CNBC provides context on Holmes’ trial and the film’s Telluride premiere. The reportage presents a spectrum of opinions, from admiration to critique, including reactions from John Carreyrou and Grimes.
Go deeper
- What new details about Evans’ role in Theranos 2.0 have emerged?
- How are investors, engineers and the public responding to the documentary?
- What does this mean for future healthcare-tech startups?
More on these topics
-
Nathan Fielder - Canadian writer
Nathan Joseph Fielder is a Canadian writer, comedian, actor, and entrepreneur. He is best known for co-creating and starring in the Comedy Central show Nathan for You.
-
Elizabeth Holmes - American biotechnology entrepreneur convicted of fraud
Elizabeth Anne Holmes (born February 3, 1984) is an American biotechnology entrepreneur who was convicted of fraud in connection with her blood-testing company, Theranos. The company's valuation soared after it claimed to have revolutionized blood testing
-
Theranos - Defunct American privately held health-technology company
Theranos Inc. () was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014. The company falsely claimed that it had devised blood tests that could be performed rapidly and accurately, while requiring very small amounts of blood, all using compact automated devices that the company had developed. A turning point came in 2015, when medical research professor John Ioannidis, and later, professor of clinical biochemistry Eleftherios Diamandis, along with investigative journalist John Carreyrou of The Wall Street Journal, questioned the validity of Theranos' technology. The company faced a string of legal and commercial challenges from medical authorities, investors, the U.S. Securities and Exchange Commission (SEC), the Centers for Medicare and Medicaid Services (CMS), state attorneys general, former business partners, patients, and others. By June 2016, Forbes estimated that Holmes's personal net worth had dropped from $4.5 billion to...
-
San Francisco - City in California
San Francisco, officially the City and County of San Francisco and colloquially known as The City, SF, or Frisco and San Fran, is the cultural, commercial, and financial center of Northern California.
-
Lance Oppenheim - American filmmaker
Lance Oppenheim is an American filmmaker, documentarian, and producer from Fort Lauderdale, Florida. His work blends cinematic genres to explore the lives of people who create homes in unconventional spaces and places.